" class="no-js "lang="en-US"> Allegheny Health Network - Medtech Alert
Friday, September 12, 2025

Breaking News

Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Astellas and Cullgen Enter into Strategic Collaboration and Option Agreement to Advance Innovative Targeted Protein Degraders Auxilius Pharma Raises Seed Funding of $1 Million and Commences its Clinical Program Captivate Bio and EverCell Bio partner on Human Cell Modeling Services for Cell and Gene Therapy Markets Applied StemCell Partners with CIRM to Provide Clinical-Grade iPSCs and Access to Its Proprietary Gene Editing Technologies Alentis Therapeutics Receives IND Clearance from FDA for ALE.C04 for the Treatment of CLDN1+ Tumors
Allegheny Health Network | Pharmtech Focus

Allegheny Health Network

About Allegheny Health Network

Allegheny Health Network

Allegheny Health Network (AHN) is a patient-centered and physician-led health network that includes hospitals, Health + Wellness Pavilions, primary and specialty care offices, and more. Our Pittsburgh-based health care system, which employs more than 21,000 people, brings together the brightest health professionals to offer patients a high quality, innovative and cost-effective health care. AHN is a proud part of Highmark Health.

Related Story

Cardiovascular

 Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology | Pharmtech Focus

Biosense Webster Launches the OCTARAY™ Mapping Catheter with TRUEref™ Technology

September 7 2022

Biosense Webster, Inc., part of Johnson & Johnson MedTech[†], today announced the release of the […]

Diseases

 Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care | Pharmtech Focus

Illumina and Allegheny Health Network to Assess In-House Comprehensive Cancer Genomic Profiling to Enhance Patient Care

May 19 2022

Illumina, Inc. (NASDAQ: ILMN) a global leader in DNA sequencing and array-based technologies, and Allegheny Health […]